Have a Heart CEO Says Flipping of Company Not Legit

San Francisco-based dispensary got flipped by three different owners in two months, including to High Times.

Cannabis Is Looking More Like a Defensive Category

Cannabis companies are finally feeling like this is their moment to shine.

Want to Invest in One of the Trashier Names? Try Tilray

It's not something momentum traders would care about in the short-run, but if we do see a squeeze, don't be greedy.

The Covid 420 Celebration Becomes a House Party

Cannabis is looking like a true recession resistant item.

Cannabis Has Become a Major Threat to Alcohol

Cannabis beverages still remain at the bottom of the sales charts. The switch to cannabis hasn't saved the day yet for alcohol companies.

Trading Appears Awry, and I'm Watching SPY

Here are the reversals I'm looking for on Monday on the SPDR S&P 500 exchange-traded fund trust.

A Mellow 420 Holiday for the Cannabis Industry This Year

This year the Covid-19 lockdown has killed the cannabis celebration buzz.

Investors Waking Up to New Cannabis Opportunity: Sleep Aids

Studies appear to back up some cannabis products' use in helping users catch needed z's.

Once Considered the Greats, These Pot Players Now Look Burnt Out

Several companies that had appeared promising are now blaming the Covid-19 crisis as they fail to turn over a new leaf for the better.

Psychedelics May Find Legit Place in Pharma as Pandemic Takes Toll

As crisis turns into one of mental health as well as physical health, some firms are experimenting with use of LSD and 'magic mushroom' compounds.